CD36
舒张期
内科学
内分泌学
基因敲除
医学
血糖性
胰岛素
2型糖尿病
体内
糖尿病
心脏病学
受体
生物
血压
细胞培养
生物技术
遗传学
作者
Jiabing Zhan,Kunying Jin,Nan Ding,Yufei Zhou,Hao Guo,Shuai Yuan,Rong Xie,Zheng Wen,Chen Chen,Huaping Li,Dao Wen Wang
标识
DOI:10.1016/j.omtn.2022.12.009
摘要
Intensive glycemic control is insufficient for reducing the risk of heart failure among patients with diabetes mellitus (DM). While the "hyperglycemic memory" phenomenon is well documented, little is known about its underlying mechanisms. In this study, a type 1 DM model was established in C57BL/6 mice using streptozotocin (STZ). Leptin receptor-deficient (db/db) mice were used as a model of type 2 DM. A type 9 adeno-associated virus was used to overexpress or knock down miR-320 in vivo. Diastolic dysfunction was observed in the type 1 DM mice with elevated miR-320 expression. However, glycemic control using insulin failed to reverse diastolic dysfunction. miR-320 knockdown protected against STZ-induced diastolic dysfunction. Similar results were observed in the type 2 DM mice. In vitro, we found that miR-320 promoted CD36 expression, which in turn induced further miR-320 expression. CD36 was rapidly induced by hyperglycemia at protein level compared with the much slower induction of miR-320, suggesting a positive feedback loop of CD36/miR-320 with CD36 protein induction as the initial triggering event. In conclusion, in DM-induced cardiac injury, miR-320 and CD36 mutually enhance each other's expression, leading to a positive feedback loop and a sustained hyperlipidemic state in the heart.
科研通智能强力驱动
Strongly Powered by AbleSci AI